GAGANDEEP SAMRA: Open Payments
NPI 1275183618 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,273 in 127 payments from 24 companies in 2025. Trend: 2023 $2,653 · 2024 $2,876 · 2025 $2,273
Food & beverage: $2,204Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $581 |
| Janssen Biotech, Inc. | 15 | $271 |
| Incyte Corporation | 18 | $215 |
| GENZYME CORPORATION | 6 | $168 |
| UCB, Inc. | 5 | $119 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $100 |
| Amgen Inc. | 6 | $97 |
| Smith+Nephew, Inc. | 3 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| LEO Pharma Inc. | 4 | $76 |
Products named: SKYRIZI, TREMFYA, RINVOQ, DUPIXENT, OPZELURA, Bimzelx, Otezla, ADBRY.
Industry payments across CA — which companies pay providers there.
